Glossary
Kimberly Lewandowski-walker
FDA Investigator Details
Kimberly Lewandowski-walker
Visit Investigator ProfileInvestigation Details
Last Issued Date
March 29, 2010
Conversion Rate
0
% Conversion
No. of 483’s Issued
1
Warning Letters Issued
0
Countries Inspected
USA
FDA Investigators having one site common
Detailed Analysis
Approach:
Lewandowski-Walker emphasizes on thorough implementation of quality systems across the organization. She prefers a detailed probe into the core of the nonconformities and seeks robust preventive measures to control the occurrence of nonconforming product and other quality issues.
Profile:
FDA investigator Kimberly Lewandowski-Walker has shown keen interest in thoroughly inspecting the integrity of a company's quality system management, the depth of nonconformity investigations, and the sufficiency of preventive actions. She tends to focus on broad, systemic quality issues and how well an organization capably addresses and prevents such issues from recurring.
Top Process Types:
Issue Date
Facility Name
Product Type
Form 483
Converted
Warning Letter
Unlock Insights from 483s & Stay Audit Ready with FDA Tracker
Monitor FDA Six Systems, Analyse 483s with Observations, Investigators & Companies
Get Started Now
